XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3Close
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 335 $ 236
Short-term investments 6 3
Accounts receivable, net 1,380 1,411
Inventories 1,502 1,597
Prepaid expenses 66 62
Total current assets 3,289 3,309
Property, plant and equipment, net of accumulated depreciation of $3,455 and $3,326, respectively 2,401 2,407
Intangible assets, net of accumulated amortization of $291 and $275, respectively 1,296 1,301
Other assets 563 544
Total assets 7,549 7,561 Close
Current liabilities:    
Short-term borrowings 466 543
Accounts payable and accrued liabilities 1,202 1,339
Total current liabilities 1,668 1,882
Long-term debt 1,940 1,940
Other non-current liabilities 474 477
Total liabilities 4,082 4,299 Close
Share-based payments subject to redemption 49 48
Redeemable non-controlling interests 41 51 Close
Ingredion stockholders’ equity:    
Preferred stock — authorized 25,000,000 shares — $0.01 par value, none issued 0 0
Common stock — authorized 200,000,000 shares — $0.01 par value, 77,810,875 issued at September 30, 2023 and December 31, 2022 1 1
Additional paid-in capital 1,143 1,132
Less: Treasury stock (common stock: 12,623,174 and 12,116,920 shares at September 30, 2023 and December 31, 2022, respectively) at cost (1,211) (1,148)
Accumulated other comprehensive loss (1,144) (1,048)
Retained earnings 4,575 4,210
Total Ingredion stockholders’ equity 3,364 3,147
Non-redeemable non-controlling interests 13 16
Total equity 3,377 3,163 Close
Total liabilities and equity $ 7,549 $ 7,561